You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 6, June 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (4)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ophthalmological Disorders, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Persistent Fetal Ocular Vasculature in Mice Deficient in Bax and Bak

Paul Hahn, PhD; Tullia Lindsten, MD, PhD; Michael Tolentino, MD; Craig B. Thompson, MD; Jean Bennett, MD, PhD; Joshua L. Dunaief, MD, PhD

Arch Ophthalmol. 2005;123:797-802.

Background  The ocular fetal vasculature normally regresses by apoptosis but for unknown reasons fails to regress in the human disease persistent fetal vasculature.

Objective  To investigate whether proapoptotic Bcl-2 members, Bax and Bak, are involved in fetal vasculature regression.

Methods  Adult eyes from mice deficient in Bax and/or Bak were examined grossly and histologically for persistence of fetal vasculature. Vessels were identified by the presence of lumens and erythrocytes and by Factor VIII labeling. Eyes from postnatal day 7 mice were processed for terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling (TUNEL) analysis to determine if deficiency of Bax and Bak results in defective developmental apoptosis.

Results  Only bax–/–bak–/– eyes retained fetal vasculature into adulthood. This vasculature consisted of a hyaloid artery emerging from the optic nerve head and intravitreal and perilental vessels but not a pupillary membrane. At postnatal day 7, wild-type but not bax–/–bak–/– eyes had TUNEL-positive cells in the fetal vasculature.

Conclusions  These data demonstrate that Bax and Bak serve overlapping functions in fetal vasculature regression, emphasizing the importance of apoptosis in developmental remodeling.

Clinical Relevance  Disruption of Bax and Bak results in persistent fetal vasculature in knockout mice, providing a model of the human disease persistent fetal vasculature to investigate its etiology and potential therapies.


Author Affiliations: F.M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute (Drs Hahn, Tolentino, Bennett, and Dunaief); Departments of Medicine, Pathology, and Laboratory Medicine, Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia (Drs Lindsten and Thompson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Nonautonomous Role for Retinal Frizzled-5 in Regulating Hyaloid Vitreous Vasculature Development
Zhang et al.
IOVS 2008;49:5561-5567.
ABSTRACT | FULL TEXT  

Effect of ANG II on endothelial cell apoptosis and survival and its impact on skeletal muscle angiogenesis after electrical stimulation
de Resende and Greene
Am. J. Physiol. Heart Circ. Physiol. 2008;294:H2814-H2821.
ABSTRACT | FULL TEXT  

Ocular Abnormalities in Mice Lacking the Ski Proto-oncogene.
McGannon et al.
IOVS 2006;47:4231-4237.
ABSTRACT | FULL TEXT  

Role of endothelial cell apoptosis in regulation of skeletal muscle angiogenesis during high and low salt intake
de Resende et al.
Physiol. Genomics 2006;25:325-335.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.